Phase I study of ZD6474 [vandetanib] and temozolomide in patients with advanced cancer

Trial Profile

Phase I study of ZD6474 [vandetanib] and temozolomide in patients with advanced cancer

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 07 Mar 2014

At a glance

  • Drugs Temozolomide (Primary) ; Vandetanib (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top